Harsh works with managed care organizations, hospital systems, and other providers on a wide range of regulatory, reimbursement, and transactional matters. His practice encompasses federal and California fraud and abuse compliance, licenses and permits, Medicare and Medicaid (Medi-Cal) participation and reimbursement, False Claims Act internal and government investigations, and enforcement actions. Harsh also advises clients on health information technology, bioethics, privacy, security compliance, digital health, and telemedicine matters.
I assist clients in complex transactions involving sales and acquisitions of clinics, pharmacies, and hospitals. With deep experience handling regulatory issues implicated in health care transactions, I often serve as the regulatory counsel on a range of transactions involving state and federal agencies, including the Center for Medicare and Medicaid (CMS), California Department of Health Care Services (DHCS), California Department of Public Health (CDPH), the Medical Board of California (MBC), and the California State Board of Pharmacy. Additionally, I provide critical analysis and health care compliance advice on a variety of business arrangements with health plans, physicians, mental health providers, hospitals, and drug and device manufacturers.
I regularly advise clients on compliance with federal and California health care laws, with an emphasis on assessing False Claims Act risk and resolving self-disclosure obligations under the Stark Law and Anti-Kickback Statute. I have successfully defended clients seeking resolution of government health care program overpayment issues through negotiated settlements. For example, I recently coordinated a major health system’s internal investigation of its billing practices and its voluntary self-disclosure to the Department of Health and Human Services, Office of the Inspector General. I’ve also led multiple compliance investigations and provider self-disclosures to federal and state agencies of unlicensed staff, cost report errors, EMTALA violations, and HIPAA security breaches.
I’ve worked on numerous Medicare and Medicaid reimbursement/audit matters, including representing clients in administrative hearings.
As health policy dominates the current political discourse, federal health care reform seems inevitable. Rising health care costs hampered the Affordable Care Act’s vision of universal coverage. The key will be whether lawmakers can balance the need to bend the cost curve without sacrificing innovation in medicine. Even without legislative action, government payors will move full speed ahead with shifting Medicare and Medi-Cal payment models. The need to achieve greater economies of scale will drive continued consolidation in the industry for both payors and providers.
There are also significant opportunities for disruption in health care. Seamless aggregation of medical data and deep learning of medical literature by artificial intelligence (AI) promises to guide the future of patient care. Such advances in health care technology will present complex legal challenges for stakeholders.
New Hampshire Bar News | January 15, 2020
Manchester Complex Commercial Disputes associate Kierstan Schultz and Los Angeles Health Care associate Harsh Parikh co-wrote this contributed article analyzing two new rules proposed by the Department of Health and Human Services aimed at addressing perceived barriers to care coordination and value-based care in the health industry.
Health Care Alert | 10.07.20
Health Care Alert | 07.28.20
Heath Care Alert | 04.24.20
Health Care Alert | 04.13.20
Health Care Alert | 03.18.20
Health Care Alert | 11.20.19
Health Care Alert | 10.24.19
10.29.20 | Virtual Event
01.21.20 | Los Angeles, CA
11.14.19 | Webinar
University of California, Los Angeles School of Law, J.D.
University of California, Los Angeles, B.A.